Biologic therapy in primary systemic vasculitis of the young

Creative Commons License

Eleftheriou D., Melo M., Marks S. D., Tullus K., Sills J., Cleary G., ...Daha Fazla

RHEUMATOLOGY, cilt.48, sa.8, ss.978-986, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 48 Sayı: 8
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1093/rheumatology/kep148
  • Dergi Adı: RHEUMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.978-986
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Methods. This was a retrospective descriptive case series of children with PSV treated with biologic therapy between February 2002 and November 2007. Primary retrospective outcome assessment measures were: daily corticosteroid dose; Birmingham Vasculitis Activity Score (BVAS); and adverse events (including infection rate).